Albireo Pharma Stock Options


USD 21.78  0.35  1.63%   

Albireo Pharma's option chain provides insight into all available option contracts written on Albireo Pharma's stock. Investors can see outstanding put and call contracts with pricing information and greeks for a given expiration period. In addition, each of Albireo Pharma's stock options below provides a detailed picture of the payoff. Comparing vital and dynamic information of various option contracts across diverse expiration periods will help you make an educated decision on your market timing strategies around investing in a given Albireo option contract. View S&P 500 options
Purchasing Albireo Pharma options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Albireo calls. Remember, the seller must deliver Albireo Pharma stock to the call owner when a call is exercised.

In The Money vs. Out of Money Option Contracts on Albireo Pharma

Analyzing Albireo Pharma's in-the-money options over time can help investors to take a profitable long position in Albireo Pharma regardless of its overall volatility. This is especially true when Albireo Pharma's options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Albireo Pharma's options could be used as guardians of the underlying stock as they move almost dollar for dollar with Albireo Pharma's stock while costing only a fraction of its price.
Albireo Pharma's latest option contracts expiring on 2022-12-16 are carrying combined implied volatility of 79.16 with a put-to-call open interest ratio of 0.08 over 16 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on 2022-12-16. The current put volume is at 1, with calls trading at the volume of 9. This yields a 0.11 put-to-call volume ratio. The Albireo Pharma option chain provides detailed quote and price information for the current Albireo Pharma option contracts. It shows all of Albireo Pharma's listed puts, calls, expiration dates, strike prices, and other pricing information.

Open Interest Against 2022-12-16 Option Contracts

Albireo Pharma option prices can potentially be used to forecast stock returns because most option chains provide information not only about the current prices but also about the future conditions in Albireo Pharma's lending market. For example, when Albireo Pharma's puts are not actively trading or completely missing in the marketplace, investors can use it to internalize expected shorting costs. So if an investor is writing a put option on Albireo Pharma, he or she must hedge the risk by shorting Albireo Pharma stock over its option's life.
The chart above shows Albireo Pharma's distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Albireo Pharma's open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Albireo Pharma's option, there is no secondary market available for investors to trade.
Albireo Pharma's stock options are financial instruments that give investors the right to buy or sell shares of Albireo Pharma common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell Albireo stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If Albireo Pharma's stock price goes up or down, the stock options follow.
Please continue to Trending Equities.
Please note that buying 'in-the-money' options on Albireo Pharma lessens the impact of time decay, as they carry both intrinsic and time value. So, even if Albireo Pharma's value remains static through the expiration date, the investor can sell to close an 'in-the-money' option to avoid a potential loss. However, in-the-money Albireo Pharma contracts are usually more expensive to enter than their out-of-the-money counterparts. So keep in mind that while the payoffs on an in-the-money trade can be high, the investors could ultimately experience a more consequential loss if Albireo Stock moves the wrong way.
The value of Net Income Common Stock is estimated to slide to about (36.7 M)

Albireo Pharma In The Money Call Balance

When Albireo Pharma's strike price is surpassing the current stock price, the option contract against Albireo Pharma stock is said to be in the money. When it comes to buying Albireo Pharma's options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Albireo Pharma are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.

Albireo Current Options Market Mood

Albireo Pharma's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Albireo Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.

Put-to-Call Open Interest

Put-to-Call Volume

Most options investors, including buyers and sellers of Albireo Pharma's calls and puts, are not very successful. It is estimated that an average options trader loses somewhere between 80% to 90% of the time. Albireo Pharma's option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction. Using current Albireo Pharma's option volume and open interest to make an investment decision is considered a contrarian-sentiment measure that can be utilized in many timing strategies in both derivative and spot marketplace.

Rule 16 of the current Albireo contract

Base on the Rule 16, the options market is currently suggesting that Albireo Pharma will have an average daily up or down price movement of about 4.95% per day over the life of the 2022-12-16 option contract. With Albireo Pharma trading at $21.78, that is roughly $1.08. If you think that the market is fully incorporating Albireo Pharma's daily price movement you should consider buying Albireo Pharma options at the current volatility level of 79.16%. But if you have an opposite viewpoint you should avoid it and even consider selling them.

Albireo Pharma Option Chain

When Albireo Pharma's strike price is surpassing the current stock price, the option contract against Albireo Pharma stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Albireo Pharma's option chain is a display of a range of information that helps investors for ways to trade options on Albireo. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Albireo. It also shows strike prices and maturity days for a Albireo Pharma against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.
DeltaGammaOpen IntExpirationCurrent SpreadLast Price
2022-12-16 CALL at $10.00.91790.009402022-12-1610.3 - 12.30.0In
2022-12-16 CALL at $12.50.98010.00802022-12-168.2 - 9.80.0In
2022-12-16 CALL at $15.00.83220.023202022-12-165.2 - 7.70.0In
2022-12-16 CALL at $17.50.85110.049402022-12-162.85 - 5.34.36In
2022-12-16 CALL at $20.00.67260.082132022-12-161.75 - 3.32.6In
2022-12-16 CALL at $22.50.40450.1215492022-12-160.5 - 1.21.45Out
2022-12-16 CALL at $25.00.12090.07592002022-12-160.05 - 1.90.15Out
2022-12-16 PUT at $20.0-0.32430.085102022-12-160.25 - 1.750.0Out
2022-12-16 PUT at $22.5-0.64150.15402022-12-161.5 - 3.81.6In
2022-12-16 PUT at $25.0-0.94580.055202022-12-162.6 - 4.60.0In
2022-12-16 PUT at $30.0-0.77280.03902022-12-167.4 - 9.40.0In

Albireo Pharma Net Income Common Stock Over Time

The amount of net income (loss) for the period due to common shareholders. Typically differs from Net Income to the parent entity due to the deduction of Preferred Dividends.
   Net Income Common Stock   

Albireo Pharma Historical Liabilities

While analyzing the current debt level is an essential aspect of forecasting the current year budgeting needs of Albireo Pharma, understanding its historical liability is critical in projecting Albireo Pharma's future earnings, especially during periods of low and high inflation and deflation. Many analysts look at the trend in assets and liabilities and evaluate how Albireo Pharma uses its financing power over time.

Albireo Pharma Investors Sentiment

The influence of Albireo Pharma's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Albireo. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.
Investor biases related to Albireo Pharma's public news can be used to forecast risks associated with investment in Albireo. The trend in average sentiment can be used to explain how an investor holding Albireo can time the market purely based on public headlines and social activities around Albireo Pharma. Please note that most equiteis that are difficult to arbitrage are affected by market sentiment the most.
Albireo Pharma's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Albireo Pharma's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Albireo Pharma's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Albireo Pharma.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Albireo Pharma in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Albireo Pharma's short interest history, or implied volatility extrapolated from Albireo Pharma options trading.

Pair Trading with Albireo Pharma

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Albireo Pharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Albireo Pharma will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Albireo Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Albireo Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Albireo Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Albireo Pharma to buy it.
The correlation of Albireo Pharma is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Albireo Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Albireo Pharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Albireo Pharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Please continue to Trending Equities. Note that the Albireo Pharma information on this page should be used as a complementary analysis to other Albireo Pharma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Complementary Tools for Albireo Stock analysis

When running Albireo Pharma price analysis, check to measure Albireo Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Albireo Pharma is operating at the current time. Most of Albireo Pharma's value examination focuses on studying past and present price action to predict the probability of Albireo Pharma's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Albireo Pharma's price. Additionally, you may evaluate how the addition of Albireo Pharma to your portfolios can decrease your overall portfolio volatility.
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Is Albireo Pharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Albireo Pharma. If investors know Albireo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Albireo Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
454.3 M
Quarterly Revenue Growth YOY
Return On Assets
Return On Equity
The market value of Albireo Pharma is measured differently than its book value, which is the value of Albireo that is recorded on the company's balance sheet. Investors also form their own opinion of Albireo Pharma's value that differs from its market value or its book value, called intrinsic value, which is Albireo Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Albireo Pharma's market value can be influenced by many factors that don't directly affect Albireo Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Albireo Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine Albireo Pharma value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Albireo Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.